307 related articles for article (PubMed ID: 29751014)
1. A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.
Jayavaradhan R; Pillis DM; Malik P
J Mol Biol; 2019 Jan; 431(1):102-110. PubMed ID: 29751014
[TBL] [Abstract][Full Text] [Related]
2. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
[TBL] [Abstract][Full Text] [Related]
3. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
4. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
5. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
6. Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.
Chen Y; Wen R; Yang Z; Chen Z
Gene Ther; 2022 May; 29(5):207-216. PubMed ID: 33750926
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
8. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
Feng Y; Liu S; Chen R; Xie A
J Zhejiang Univ Sci B; 2021 Jan; 22(1):73-86. PubMed ID: 33448189
[TBL] [Abstract][Full Text] [Related]
9. CRISPR as a strong gene editing tool.
Shen S; Loh TJ; Shen H; Zheng X; Shen H
BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
[TBL] [Abstract][Full Text] [Related]
10. Exogenous gene integration mediated by genome editing technologies in zebrafish.
Morita H; Taimatsu K; Yanagi K; Kawahara A
Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
[TBL] [Abstract][Full Text] [Related]
11. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
12. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
13. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
Mandal PK; Ferreira LM; Collins R; Meissner TB; Boutwell CL; Friesen M; Vrbanac V; Garrison BS; Stortchevoi A; Bryder D; Musunuru K; Brand H; Tager AM; Allen TM; Talkowski ME; Rossi DJ; Cowan CA
Cell Stem Cell; 2014 Nov; 15(5):643-52. PubMed ID: 25517468
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of CRISPR/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells.
Park SH; Lee CM; Bao G
Methods Mol Biol; 2022; 2429():281-306. PubMed ID: 35507169
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
[TBL] [Abstract][Full Text] [Related]
18. Finally, Archaea Get Their CRISPR-Cas Toolbox.
Gophna U; Allers T; Marchfelder A
Trends Microbiol; 2017 Jun; 25(6):430-432. PubMed ID: 28391963
[TBL] [Abstract][Full Text] [Related]
19. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
